Some
of the most dangerous bacterial pathogens (Gram-negative
and
mycobacterial) deploy a formidable secondary membrane barrier to reduce
the influx of exogenous molecules. For Gram-negative bacteria, this
second exterior membrane is known as the outer membrane (OM), while
for the Gram-indeterminate Mycobacteria, it is known as the “myco” membrane. Although different
in composition, both the OM and mycomembrane are key structures that
restrict the passive permeation of small molecules into bacterial
cells. Although it is well-appreciated that such structures are principal
determinants of small molecule permeation, it has proven to be challenging
to assess this feature in a robust and quantitative way or in complex,
infection-relevant settings. Herein, we describe the development of
the bacterial chloro–alkane penetration assay (BaCAPA), which
employs the use of a genetically encoded protein called HaloTag, to
measure the uptake and accumulation of molecules into model Gram-negative
and mycobacterial species, Escherichia coli and Mycobacterium smegmatis, respectively,
and into the human pathogen Mycobacterium tuberculosis. The HaloTag protein can be directed to either the cytoplasm or
the periplasm of bacteria. This offers the possibility of compartmental
analysis of permeation across individual cell membranes. Significantly,
we also showed that BaCAPA can be used to analyze the permeation of
molecules into host cell-internalized E. coli and M. tuberculosis, a critical capability
for analyzing intracellular pathogens. Together, our results show
that BaCAPA affords facile measurement of permeability across four
barriers: the host plasma and phagosomal membranes and the diderm
bacterial cell envelope.